STERIS’ (TSE:STE – Free Report) – Research analysts at Atb Cap Markets raised their Q1 2025 earnings estimates for shares of STERIS’ in a note issued to investors on Wednesday, March 12th. Atb Cap Markets analyst W. Syed now expects that the company will post earnings per share of $0.35 for the quarter, up from their prior estimate of $0.29. Atb Cap Markets currently has a “Strong-Buy” rating on the stock. Atb Cap Markets also issued estimates for STERIS’’s Q3 2025 earnings at $0.27 EPS, Q1 2026 earnings at $0.40 EPS, Q2 2026 earnings at $0.12 EPS, Q3 2026 earnings at $0.32 EPS, FY2026 earnings at $0.75 EPS and FY2027 earnings at $0.89 EPS.
Separately, Cormark upgraded shares of STERIS’ to a “moderate buy” rating in a research report on Monday, January 6th.
STERIS’ Price Performance
About STERIS’
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Featured Stories
- Five stocks we like better than STERIS’
- Investing in the High PE Growth Stocks
- 3 Undervalued Stocks You Can Buy at a Discount Now
- Stock Sentiment Analysis: How it Works
- AMD Stock: Can the PC Refresh Cycle Spark a Rally?
- How to invest in marijuana stocks in 7 steps
- Micron Stock Spikes 7%—3 Key Catalysts Behind the Move
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
